Barely Significant
← all excerpts

The treatment of generalized anxiety disorder with pregabalin, an atypical anxiolytic.

Neuropsychiatr Dis Treat · 2007 · PMC2654629 · PMID 19300556

Europe PMCDOI
1
hedged sentence
0.0600
closest p · 1.2× alpha
0.0600
boldest claim

The sentences

a statistical trendp = 0.06so close (0.05 < p ≤ 0.1)
Pande et al (2003) found PWC scores to be significantly higher than placebo for patients receiving lorazepam (6 mg/day) and noted a statistical trend (p = 0.06) for patients receiving pregabalin 600 mg/day to have increased discontinuation-related anxiety symptoms, but found no difference in PWC score between pregabalin 150 mg/day and placebo ( Pande et al 2003 ).

also in 2,798 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.